Reassessment of nefazodone.
作者信息
Bryant S G
出版信息
Am J Health Syst Pharm. 1996 Oct 1;53(19):2339-40, 2343. doi: 10.1093/ajhp/53.19.2339.
PMID:8893078
Abstract
摘要
相似文献
1
Reassessment of nefazodone.奈法唑酮的重新评估。
Am J Health Syst Pharm. 1996 Oct 1;53(19):2339-40, 2343. doi: 10.1093/ajhp/53.19.2339.
2
Sertraline-induced anorgasmia treated with intermittent nefazodone.
J Clin Psychiatry. 1997 Feb;58(2):89. doi: 10.4088/jcp.v58n0206f.
3
[New antidepressive agents].[新型抗抑郁药]
Union Med Can. 1995 Nov;124(3):8-13.
4
5
Withdrawal syndromes after paroxetine and sertraline discontinuation.帕罗西汀和舍曲林停药后的戒断综合征。
J Clin Psychopharmacol. 1995 Oct;15(5):374-5. doi: 10.1097/00004714-199510000-00012.
6
Dystonia associated with trazodone and sertraline.与曲唑酮和舍曲林相关的肌张力障碍。
J Clin Psychopharmacol. 1997 Feb;17(1):64-5. doi: 10.1097/00004714-199702000-00020.
7
Incentive bias?激励偏差？
J Clin Psychiatry. 1996 Jun;57(6):265; author reply 267-9.
8
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
J Clin Psychiatry. 1995;56 Suppl 6:12-21.
9
Toxic effects of nefazodone.奈法唑酮的毒性作用。
Ann Emerg Med. 1997 Oct;30(4):551.
10
SSRI optimal dose remains at issue.
J Clin Psychiatry. 1997 Feb;58(2):87-8. doi: 10.4088/jcp.v58n0206d.
Zotero 插件